SleepScriptMD expands online trazodone reviews to 42 states

SleepScriptMD is now offering online physician reviews for trazodone for sleep in 42 U.S. states, with approved prescriptions sent to a patient’s chosen local pharmacy. The rollout extends the telehealth platform’s same-day style workflow to more people seeking help for trouble falling or staying asleep.

Why it matters: - SleepScriptMD’s expansion gives more patients access to a prescription sleep option without an in-person visit. - The service targets people who have trouble falling asleep, staying asleep or waking repeatedly. - Approved prescriptions are sent to a local pharmacy, which can shorten the path from review to treatment. - The platform says it does not prescribe controlled substances.

What happened: - SleepScriptMD now prescribes trazodone for sleep to patients in 42 U.S. states. - Patients can request an online physician review and choose a local pharmacy for fulfillment. - The company says reviews happen entirely online, with no live appointment, video call or waiting room. - The review starts with a five-minute online medical form. - A licensed doctor then reviews the information asynchronously and decides whether a medication is appropriate.

The details: - SleepScriptMD says most reviews are completed within 24 hours. - The company says approved prescriptions can reach the patient’s pharmacy within two to four hours. - Trazodone is also known by the brand names Desyrel and Oleptro. - The platform says trazodone is commonly used at lower doses for sleep when a clinician decides it fits the case. - Patient education materials say trazodone is often taken in the evening or at bedtime based on clinician instructions. - Listed possible side effects include next-day drowsiness, dry mouth, headache and dizziness. - Patients are advised to seek care for unusual or severe symptoms. - The company advises patients to discuss other serotonergic medications, alcohol use and fall risk before starting trazodone. - SleepScriptMD says that guidance is educational and does not replace clinician advice, prescription labels or pharmacist counseling. - Alongside trazodone, the platform evaluates clonidine, hydroxyzine, ramelteon and doxepin. - The company describes those medicines as non-addictive options when appropriate. - The review costs $69 one time, with no recurring charges. - The review includes the sleep intake and history evaluation, personalized prescriptions sent to the pharmacy, access to the medical team and lifestyle guidance. - SleepScriptMD offers a 100% refund to patients who are not candidates for treatment.

Between the lines: - The company is positioning asynchronous telehealth as a faster, lower-friction route for patients who have been delaying sleep care. - Patient testimonials in the release frame convenience and speed as major drivers of use. - SleepScriptMD says patient information is reviewed by board-certified providers and licensed clinicians with sleep medicine experience. - The company lists LegitScript, HIPAA compliance and 100% U.S.-licensed physicians among its credentials. - SleepScriptMD says more than 5,000 patients have been reviewed on the platform. - The service is co-founded by Dr. Peter Kelly, a family medicine physician, and Dr. David Danish, who is dual board certified in child/adolescent and adult psychiatry. - David Danish, MD, is featured on the company’s website explaining the sleep care process.

What's next: - Patients seeking a review can start on SleepScriptMD’s website or call +1 800-737-8385. - State telehealth rules will continue to shape where the asynchronous review pathway is available. - The company’s next growth likely depends on how quickly it can keep expanding access while staying within state-by-state prescribing requirements.

The bottom line: - SleepScriptMD is using online physician review to make non-controlled sleep medication access faster and more convenient across a wider share of the U.S.